tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports

Keros Therapeutics (KROS) Stock News & Sentiment

Compare
359 Followers
Promising Future for Keros Therapeutics: Buy Rating Backed by Strategic Focus and Key Partnerships
Premium
Ratings
Promising Future for Keros Therapeutics: Buy Rating Backed by Strategic Focus and Key Partnerships
2M ago
KROS
Keros Therapeutics Reports Strong Revenue Growth
Premium
Company Announcements
Keros Therapeutics Reports Strong Revenue Growth
2M ago
KROS
Keros Therapeutics: Hold Rating Amid Strategic Focus on KER-065 and Financial Uncertainties
Premium
Ratings
Keros Therapeutics: Hold Rating Amid Strategic Focus on KER-065 and Financial Uncertainties
2M ago
KROS
Keros Therapeutics: Strategic Focus on KER-065 and Financial Position Justifies Hold Rating
Premium
Ratings
Keros Therapeutics: Strategic Focus on KER-065 and Financial Position Justifies Hold Rating
2M ago
KROS
Keros Therapeutics Announces $375M Capital Return Program
Premium
Company Announcements
Keros Therapeutics Announces $375M Capital Return Program
2M ago
8K
KROS
Keros Therapeutics Presents Promising Phase 1 Trial Data
Premium
Company Announcements
Keros Therapeutics Presents Promising Phase 1 Trial Data
4M ago
8K
KROS
Keros Therapeutics CEO to Speak at Healthcare Conferences
Premium
Company Announcements
Keros Therapeutics CEO to Speak at Healthcare Conferences
4M ago
8K
KROS
More KROS News >

KROS News on the Web

Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why
Zacks
Bullish
Here's Why Keros Therapeutics (KROS) Could be Great Choice for a Bottom Fisher
Zacks
Neutral
Why Keros Therapeutics, Inc.’s (KROS) Stock Is Up 5.21%
AAII
Neutral
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026
Zacks
Neutral
Zacks.com featured highlights include StoneCo, General Motors, Enersys, Deutsche, Keros
Zacks
Neutral
Buy These 5 Best Value Stocks to Boost Your Portfolio in December
Zacks
Neutral
What Makes Keros Therapeutics, Inc. (KROS) a Strong Momentum Stock: Buy Now?
Zacks
Neutral
KROS vs. ARGX: Which Stock Is the Better Value Option?
Zacks
Neutral

News Score - Last 7 Days

Neutral
KROS
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.5 articles
News Sentiment
This Week99%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KROS’s Media Buzz Sentiment?
3 articles about KROS were published this week. In an average week, 2.5 articles are published.
    What is KROS’s weekly average amount of articles?
    In an average week, 2.5 articles about KROS are published.
      What is KROS’s News Sentiment?
      99% of articles about KROS were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        DVAXDynavax
        AGIOAgios Pharma
        PDEXPro-Dex
        EWTXEdgewise Therapeutics
        JNJJohnson & Johnson
        Showing the stocks with the most bullish news sentiment over the past week